MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0022447
Alcare Laboratories Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.13 Cr
▲ 38% YoY
Net profit · FY 2025
₹3.23 Lakh
Net margin 0.8%
EBITDA · FY 2025
₹9.83 Lakh
EBITDA margin 2.4%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1.79 Cr
Secured borrowings
Company age
23 yrs
Est. 2003
Directors on board
2
As per MCA filings
About Alcare Laboratories Private Limited
Data last updated:
Alcare Laboratories Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 May 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2003PTC120216. Its GSTIN is 07AAECA9410H1ZU (Delhi).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Raj Kumar Goel and Anju Goel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 43/1 Najafgarh Road Vishal Colony Nangloi, Delhi, India – 110041.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.13 Cr, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹3.23 Lakh (net margin 0.8%) and EBITDA of ₹9.83 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹1.79 Cr on record. Court records list 8 cases involving the company, including 6 filed by the company and 2 filed against it.
Alcare Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0022447). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alcarelab.in.
Company details
CIN U24239DL2003PTC120216
Registration Number 120216
Incorporation Date 07 May 2003
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0022447
Key People
Raj Kumar Goel Director Anju Goel Director Recognitions & Rankings of Alcare Laboratories
Contact details
Alcare Laboratories Private Limited's registered office is in Delhi, Delhi. Its website is alcarelab.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address43/1 Najafgarh Road Vishal Colony Nangloi, Delhi, India – 110041
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Alcare Laboratories Private Limited, buy the company report.
Comprehensive company report
Alcare Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Alcare Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Alcare Laboratories Private Limited, buy the company report.
Financials of Alcare Laboratories Private Limited
FY 2025 filings availableAlcare Laboratories Private Limited reported revenue of ₹4.13 Cr (up 38% YoY) for FY 2025.
Revenue · FY 2025
₹4.13 Cr ▲ 38%
Net profit · FY 2025
₹3.23 Lakh margin 0.8%
EBITDA · FY 2025
₹9.83 Lakh margin 2.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 8%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 70%
3 years · compounded
▲ 14%
5 years · compounded
▲ 7%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 38% growth in the latest year. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.83 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.23 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alcare Laboratories Private Limited, buy the company report.
Board of directors of Alcare Laboratories Private Limited
Alcare Laboratories has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Kumar Goel | Director | 07 May 2003 | 23 Years 5 Months | Current |
| Anju Goel | Director | 07 May 2003 | 23 Years 5 Months | Current |
Auditor
Alcare Laboratories Private Limited is audited by R A M M & CO LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R A M M & CO LLP | FY 2023 | 031000N/N500380 |
Shareholding
The shareholding of Alcare Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Alcare Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.79 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Sep 2024 | 100984414 | Sidbi | ₹1.79 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Alcare Laboratories Private Limited has 8 court cases on record: 6 filed by Alcare Laboratories, 2 filed against it. All cases are disposed.
Total cases
8
Filed by the company
6
Filed against the company
2
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 1 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Criminal case | Filed by the company against M/S S. N. Biotech Pvt. Ltd. | Disposed |
| District court, West, Delhi | Cheque dishonour complaint | Filed by the company against Jay Shankar Prop of M/S Jimax Pharma | Disposed |
| District court, West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
| District court, West, Delhi | Criminal case | Filed by the company against an individual | Disposed |
| District court, West, Delhi | Criminal case | Filed by the company against Atrica Pharma India Pvt Ltd | Disposed |
To see the full case history of Alcare Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alcare Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alcare Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECA9410H1ZU | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Alcare Laboratories Private Limited, buy the company report.
Recent activity
Alcare Laboratories Private Limited has 2 board changes on record since 2003: 2 appointments. The latest: Anju Goel was appointed as Director on 07 May 2003.
AGM
Alcare Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Alcare Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Sidbi amounted to Rs. 179.32 Lakh with Charge ID 100984414 was registered on 13 Sep 2024.
Appointed
Anju Goel was appointed as Director.
Appointed
Raj Kumar Goel was appointed as Director.
Incorporation
07 May 2003
Alcare Laboratories Private Limited was registered on 07 May 2003 with Roc Delhi & aged 23 years 5 months as per MCA records.
Frequently asked questions
Alcare Laboratories is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 May 2003 (23+ years old) and is registered under CIN U24239DL2003PTC120216.
Alcare Laboratories has 2 current directors:
- Raj Kumar Goel - Director
- Anju Goel - Director
The latest financial statements of Alcare Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Alcare Laboratories is 07AAECA9410H1ZU, registered in Delhi.
The CIN (Corporate Identification Number) of Alcare Laboratories is U24239DL2003PTC120216. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alcare Laboratories has 8 court cases on record: 6 filed by the company and 2 filed against it. Most are in the district courts.
Alcare Laboratories was incorporated on 07 May 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
Anju Goel was appointed as Director on 07 May 2003. Raj Kumar Goel was appointed as Director on 07 May 2003.
Yes, Alcare Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0022447).
Alcare Laboratories can be reached through the website alcarelab.in. Its registered office is in Delhi, India.